Recent Finacing
Recent Raise
Evommune is a clinical-stage biotech using a human tissue–based, skin-centered platform to discover and develop small-molecule and biologic therapies targeting mast cell, IL‑18, and IRAK4 pathways for inflammatory diseases.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
